August 2017
Blue Cross, Blue Care Network no longer cover Evzio®, effective Sept. 1
To provide appropriate therapy and affordable prescription drug benefits, Blue Cross Blue Shield of Michigan and Blue Care Network commercial (non-Medicare) plans will no longer cover the Evzio injection, effective Sept. 1, 2017.
Naloxone, the active ingredient in Evzio, is used to reverse the effects of an opioid overdose until emergency medical care can be given. Blue Cross and BCN will continue to provide coverage for more cost-effective alternative naloxone products that provide the same treatment.
The following table includes additional information about Evzio and the covered alternatives.
Available naloxone products |
Drug |
Strength and formulation |
Average cost**
(per 2 doses) |
Cost to the member as of Sept. 1, 2017 |
Evzio |
0.4mg/0.4mL and 2mg/0.4mL injection |
$4,900 |
Full cost
(not covered) |
Narcan® |
4mg nasal spray |
$150 |
Preferred brand copay |
Naloxone |
0.4mg/mL and 1mg/mL injection
(vial and syringe) |
$50 |
Generic copay |
**Cost for drug based on the average wholesale price.
If you’ve been prescribing Evzio, please discuss the covered alternatives with your patients.
|